Manufacturer
DUOPHARMA (M) SDN. BHD.
Contents
Famotidine
Indication
Hypersecretory conditions, Gastro-oesophageal reflux disease, Non-ulcer dyspepsia, Benign gastric and duodenal ulceration
Instruction
May be taken with or without food.
Drug interaction
May decrease serum concentrations of atazanavir, cefditoren, delavirdine, ketoconazole, and fosamprenavir. May decrease the absorption of dasatinib. Probenecid inhibits the renal tubular secretion of famotidine. Antacids may reduce the absorption of famotidine.
Malaysia
